Clinical Diagnostics and Research Tools Market Research Reports

  1. 30 Mar 2023  |  North America  |  Customer Research

    Global Laboratory Product Purchasing Trends, 2022–2023

    End–user Perspectives on Laboratory Spending Reveals Modest 2023 Budget Increases Following robust 2022 Spending

    Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey from October to November 2022 examining their laboratories’ product purchasing process in 2022 and expectations for 2023. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. The study presents year-o...


    Special Price $4,455.00 save 10 %

  2. 30 Dec 2022  |  North America  |  Market Research

    Trends and Growth Indicators for Physician Offices/labs in Decentralized Testing and Services

    Personalized Diagnostics Are at the Cusp of Transformational Growth

    Accelerated reforms due to COVID-19 and technologically advanced sample-in-answer-out portable, web-connected, encrypted devices that provide results in a few minutes changed the diagnostic healthcare industry. Decentralized testing empowers clinicians to make lifesaving decisions for the patient. It shortens supply chain lag time, saves costs of i...


    Special Price $2,205.00 save 10 %

  3. 19 Dec 2022  |  North America  |  Market Research

    PCR-based PoC Platforms for Infectious Disease Testing Growth Opportunities

    Multimodal and Multiplex Platforms are Expanding the Molecular PoC Testing Ecosystem

    Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...


    Special Price $2,205.00 save 10 %

  4. 19 Dec 2022  |  North America  |  Market Outlook

    Top 10 for 2023: Growth Opportunities for the Life Sciences Industry

    An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...


    Special Price $2,205.00 save 10 %

  5. 01 Dec 2022  |  North America  |  Market Research

    Global in Vitro Fertilization Services Growth Opportunities

    Disruptive Technologies and Innovative Business Models are the Key Drivers in the IVF Services Industry

    This study analyzes the in vitro fertility (IVF) services market across the globe. With infertility rates increasing across the world, assisted reproductive technologies (ART), including IVF, are gaining prominence. With technology advancements, the IVF process has undergone several modifications, with mainstream service providers such as fertility...


    Special Price $4,207.50 save 15 %

  6. 22 Sep 2022  |  North America  |  Market Research

    AI Commercial Use Cases, Impact Analyses, and Growth Opportunities in Clinical Genomics

    Integration of Clinical Genomics and AI will lead to definitive Transformational Growth in the Next Decade

    Clinical genomics regained significance during the pandemic with the development of the mRNA COVID-19 vaccine, and several non-invasive at-home test kits; an unprecedented feat in recent times. Genomics will take center stage, as large genome sequencing and research will continuously create data for new therapeutics. Artificial Intelligence (AI) an...


    Special Price $2,082.50 save 15 %

  7. 23 Aug 2022  |  North America  |  Frost Radar

    Frost Radar™: US Liquid Biopsy, 2022

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...


    Special Price $4,207.50 save 15 %

  8. 14 Mar 2022  |  North America  |  Market Outlook

    Next-generation Diagnostics Outlook, 2022

    Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth

    In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...


    Special Price $3,712.50 save 25 %

  9. 28 Feb 2022  |  North America  |  Market Research

    United States Clinical Laboratory Services Growth Opportunities

    Advanced Molecular Diagnostics and At-Home Testing are Growth Prerequisites

    The United States spends more than $3 trillion—nearly 18% of GDP—on healthcare, a massive sector. Healthcare value chain participants face dynamic environments that several trends impact, including the rise in the aging population (16.9% in 2020); chronic disease burden; regulatory challenges; integration across the care continuum; migration to...


    Special Price $1,837.50 save 25 %

  10. 22 Feb 2022  |  North America  |  Market Research

    United States Liquid Biopsy Growth Opportunities

    Non-invasive Liquid Biopsy Technology Shapes the Precision Diagnostics Landscape

    Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio. Advances in next-generation sequencing-based companion diagnosti...


    Special Price $3,712.50 save 25 %